FDA Issues Warning About Increased Risk Of Heart Inflammation Caused By Moderna Jab

Earlier this month, we reported on leaked data from a Canadian study which arrived at a disturbing conclusion: the risk of rare side effects like myocarditis and pericarditis - types of heart inflammation that are potentially deadly in some patients - was at least 2.5x higher in the Moderna jab than in its main competitor, produced by Pfizer-BioNTech.

Now, less than two weeks later, the FDA has just announced that it has updated its "Fact sheet" to reflect the higher risk of heart inflammation in male patients under the age of 40.

For all patients, the "Post-marketing" data examined by the FDA show that the risk of experiencing these side effects is highest within 7 days of receiving the second dose.

Only Pfizer has received full approval from the FDA; the Moderna jab is still technically under the emergency authorization.

Whether this will delay or in any way impact the FDA's approval of the Moderna jab remains unclear.

The observed risk is higher among males under 40 years of age than among females and older males.

Questions about the link between the mRNA jabs and heart inflammation have been circulating since these side effects were first uncovered in a group of American soldiers reporting acute chest pain after their vaccinations.

https://www.zerohedge.com/covid-19/fda-issues-warning-about-increased-risk-heart-inflammation-caused-moderna-jab